Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Foundation Medicine Obtains FDA Approval For Non Small Cell Lung Cancer Companion Diagnostic

Jul 16 2021

• By Barnaby Pickering

• Source: Alamy

Related Content

Novartis Tabrecta Is First Treatment For NSCLC With METex14 Mutation

May 06 2020

Guardant Health, Roche’s Foundation Medicine Receive FDA Companion Diagnostic Nods

Jun 01 2021

Guardant Health Launches New Firsts: Blood Test To Track Patient’s Response To Immunotherapy, Tissue-Based Test

Jun 23 2021

Related Companies

Foundation Medicine, Inc.

Novartis AG

Guardant Health, Inc.

Additional Topics

Approvals Research & Development Clinical Trials Commercial Personalized Medicine In Vitro Diagnostics Cancer Diagnostics Medical Device

More from In Vitro Diagnostics

More from Diagnostics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window